Warfarin-Induced Chest Wall and Breast Hematoma in an Elderly Female Patient With Atrial Fibrillation: Original Image

ÖZDEMİR B., BAYRAM A. S., BOLCA TOPAL N., Kumbay E.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.28, no.6, pp.992-994, 2008 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 6
  • Publication Date: 2008
  • Journal Name: TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.992-994
  • Bursa Uludag University Affiliated: Yes

Abstract

Atrial fibrillation is the most common sustained cardiac rhythm disorder. Current treatment guidelines recommend long-tern oral anticoagulation with a vitamin K antagonist, such as warfarin, in patients with atrial fibrillation who are at moderate to high risk of stroke. Bleeding is a common side effect of warfarin. The risk of severe bleeding is a small but definite (1-2% annually) result of warfarin use. Risk of bleeding is augmented if the international normalization ratio (INR) is high. We presented a case with warfarin induced chest wall and breast hematoma, which is a rare condition.